Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 6/20 | 0.45 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 2/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.31 |
| ▸ | BUB1 | O43683 | 1/20 | 0.31 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953013 | 0.92 | IL17A (0.46) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30952976 | 0.92 | IL17A (0.36) | IL17AMGAT2CDK2CCNE1GSK3B | |
| SCHEMBL30952975 | 0.91 | IL17A (0.43) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30952940 | 0.86 | IL17A (0.39) | IL17ACDK2CCNE1GSK3BMBOAT4 | |
| SCHEMBL30953337 | 0.85 | IL17A (0.33) | IL17ACTSSMGAT2CDK2CCNE1 | |
| SCHEMBL30953075 | 0.85 | IL17A (0.38) | IL17AABCB11CHRM2SLCO1B1CTSS | |
| SCHEMBL30953030 | 0.85 | IL17A (0.47) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30952974 | 0.85 | IL17A (0.42) | IL17AABCB11CHRM2SLCO1B1 | |
| SCHEMBL30953104 | 0.85 | IL17A (0.38) | IL17A | |
| SCHEMBL30953419 | 0.85 | IL17A (0.34) | IL17AABCB11CHRM2SLCO1B1CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | claimed |
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |